Momelotinib for myelofibrosis: 12-year survival data and retrospective comparison to ruxolitinib

Ayalew Tefferi, Animesh Pardanani, Kebede H. Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E433-E435
JournalAmerican journal of hematology
Issue number12
StatePublished - Dec 2022

ASJC Scopus subject areas

  • Hematology

Cite this